Streptococcus agalactiae Lehmann and Neumann (ATCC BAA-1138 )
Verified By Whole-genome Sequencing
Strain Designations A909
Isolation
Clinical specimen - septic human neonate, 1934
Biosafety Level 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Antigenic Properties Lancefield's group B, serotype Ia
Product Format freeze-dried
Preceptrol no
Genome Sequenced Strain
Streptococcus agalactiae A909, complete genome.
Type Strain no
Antigenic Properties Lancefield's group B, serotype Ia
Comments
Genome sequenced strain
Medium ATCC
Medium 44: Brain Heart Infusion Agar/Broth
ATCC
Medium 260: Trypticase soy agar/broth with defibrinated sheep blood
Growth Conditions
Temperature: 37°C
Atmosphere: Aerobic
Name of Depositor AL Jones
Special Collection ATCC
Isolation
Clinical specimen - septic human neonate, 1934
References
Lancefield RC, et al. Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens. J. Exp. Med. 142: 165-179, 1975. PubMed: 1097573
Cross References
Nucleotide (GenBank) : CP000114 Streptococcus agalactiae A909, complete genome.